← Back

Neostigmine

Cholinesterase inhibitor
Injection · Tablet1 mL · 2.5 mg · 15 mg13 brands · 7 makers
Neostigmine is a cholinesterase inhibitor used for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. Neostigmine is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Muscle Relaxants (Peripherally Acting) and Cholinesterase Inhibitors.
Generic nameneostigmine
Therapeutic classMuscle Relaxants (Peripherally Acting) and Cholinesterase Inhibitors
Form & strength (NLEM)Injection: 500 micrograms in 1 mL ampoule; 2.5 mg (metilsulfate) in 1 mL ampoule; Tablet: 15 mg (bromide)
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

INDICATIONS AND USAGE Neostigmine Methylsulfate Injection, USP is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.

From the U.S. FDA-approved label for Neostigmine. Full label: DailyMed.

INDICATIONS AND USAGE Neostigmine Methylsulfate Injection, USP is a cholinesterase inhibitor indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.

From the U.S. FDA-approved label for Neostigmine. Full label: DailyMed.

DOSAGE AND ADMINISTRATION Should be administered by trained healthcare providers Peripheral nerve stimulator and monitoring for twitch responses should be used to determine when Neostigmine Methylsulfate Injection, USP should be initiated and if additional doses are needed For reversal of NMBAs with shorter half-lives, when first twitch response is substantially greater than 10% of baseline…

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

CONTRAINDICATIONS Neostigmine Methylsulfate Injection, USP is contraindicated in patients with: known hypersensitivity to neostigmine methylsulfate (known hypersensitivity reactions have included urticaria, angioedema, erythema multiforme, generalized rash, facial swelling, peripheral edema, pyrexia, flushing, hypotension, bronchospasm, bradycardia and anaphylaxis). peritonitis or mechanical obstruction of the intestinal or urinary tract. Hypersensitivity to neostigmine Peritonitis or mechanical obstruction of the intestinal or urinary tract

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

WARNINGS AND PRECAUTIONS Bradycardia: Atropine or glycopyrrolate should be administered prior to Neostigmine Methylsulfate Injection, USP to lessen risk of bradycardia. Serious Reactions with Coexisting Conditions: Use with caution in patients with coronary artery disease, cardiac arrhythmias, recent acute coronary syndrome or myasthenia gravis. Neuromuscular Dysfunction: Can occur if large doses of Neostigmine Methylsulfate Injection, USP are administered when neuromuscular blockade is minimal; reduce dose if recovery from neuromuscular blockade is nearly complete.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

6. ADVERSE REACTIONS Most common adverse reactions during treatment: bradycardia, nausea and vomiting. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

13 products from 7 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Myostigmin 2.5mg InjectionNeostigmine (2.5mg)Neon Laboratories Ltd
Tilstigmin .5mg InjectionNeostigmine (.5mg)Tablets India Limited.
Tilstigmin 15mg TabletNeostigmine (15mg)Tablets India Limited.
Tilstigmin 2.5mg InjectionNeostigmine (2.5mg)Tablets India Limited.
Myostigmin 0.5mg Injection 1mlNeostigmine (0.5mg)Neon Laboratories Ltdpacket of 10 injections
Neomine 0.5mg InjectionNeostigmine (0.5mg)Zydus Cadilavial of 1 ml Injection
Neomine 2.5mg InjectionNeostigmine (2.5mg)Zydus Cadilavial of 5 ml Injection
Neotagmin InjectionNeostigmine (NA)Themis Medicare Ltdvial of 5 ml Injection
Neotroy 0.5mg InjectionNeostigmine (0.5mg)Troikaa Pharmaceuticals Ltdvial of 5 ml Injection
Neotroy InjectionNeostigmine (NA)Troikaa Pharmaceuticals Ltdvial of 1 ml Injection
Ostig 0.5mg InjectionNeostigmine (0.5mg)Ciron Drugs & Pharmaceuticals Pvt Ltdvial of 1 ml Injection
Tilstigmin 0.5mg InjectionNeostigmine (0.5mg)Tablets India Limitedvial of 1 ml Injection
Tilstigmin TabletNeostigmine (15mg)Tablets India Limitedstrip of 10 tablets

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Stored at 20° to 25°C (68° to 77°F); Protect from light.

Storage information from the U.S. FDA-approved label.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.